Approval belongs to a product
FDA approval is based on an evaluation of a particular product for specified uses. A molecule can have one approved indication while its use for another purpose remains unproven. The current prescribing information identifies the population, warnings, contraindications, and administration details that apply to that product.
Investigational does not mean established
A compound in clinical development may be promising, but the ongoing study is intended to resolve uncertainty. Trial participation is different from buying a substance independently. Investigators follow a protocol, apply eligibility criteria, monitor participants, and report outcomes.
A disclaimer does not prove quality
The phrases research use only and not for human consumption do not establish safety for self-administration. An online certificate does not necessarily authenticate the vial in hand, prove sterility, or establish a clinically appropriate formulation. Prescription status and compounding rules also require current, product-specific verification.
Where to verify information
Check Drugs@FDA, DailyMed, FDA safety communications, and ClinicalTrials.gov. Regulatory information can change, so read the source itself and discuss any treatment decision with a licensed clinician. This page is an educational overview and does not provide legal advice.